Clustering data with hclust algorithm for NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? (Study ST000257)

ESI positive ion mode (Endocannabinoid analysis) (Analysis AN000407)
MetaboliteStructureF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15
NA-GlyME7019230.27NA2.760.31NA0.18NA1.710.39NA0.23NA2.180.85NA
1-LGME7019100.370.612.680.141.190.100.414.090.150.590.830.502.410.210.70
2-LGME7019110.180.373.950.070.420.050.215.210.070.150.410.273.280.140.20
NO-GlyME7019220.231.371.000.22NA0.151.621.830.25NA0.222.252.270.60NA
1-AGME7019120.043.431.190.120.060.023.221.900.150.050.102.921.590.160.06
2-AGME7019130.033.411.240.090.030.013.142.310.110.020.082.651.740.120.02
1-OGME7019080.222.040.860.060.260.072.513.090.070.300.582.172.320.090.36
2-OGME7019090.082.200.970.030.100.032.833.260.030.100.212.672.310.050.14
AEAME7019200.333.940.090.130.070.494.350.080.120.060.424.650.080.140.05
DHEAME7019210.194.340.040.190.050.254.370.050.200.050.274.680.050.230.04
PEAME7019140.363.010.091.580.060.452.580.190.940.040.413.030.151.920.04
Dihomo GLA EAME7019190.693.590.230.49NA1.253.470.320.51NA0.973.170.360.59NA
OEAME7019161.322.750.090.510.201.022.840.130.590.101.413.230.140.540.12
SEAME7019150.621.670.192.650.090.461.470.171.150.040.381.890.153.230.04
aLEAME7019182.09NA0.340.75NA1.56NA0.360.69NA1.78NA0.450.99NA
LEAME7019172.592.800.210.630.331.661.510.130.470.142.011.550.140.680.14

Factors:

F1Treatment:HFD | Tissue Type:Adipose
F2Treatment:HFD | Tissue Type:Hypothalmus
F3Treatment:HFD | Tissue Type:Liver
F4Treatment:HFD | Tissue Type:Muscle
F5Treatment:HFD | Tissue Type:Plasma
F6Treatment:LFD | Tissue Type:Adipose
F7Treatment:LFD | Tissue Type:Hypothalmus
F8Treatment:LFD | Tissue Type:Liver
F9Treatment:LFD | Tissue Type:Muscle
F10Treatment:LFD | Tissue Type:Plasma
F11Treatment:SW | Tissue Type:Adipose
F12Treatment:SW | Tissue Type:Hypothalmus
F13Treatment:SW | Tissue Type:Liver
F14Treatment:SW | Tissue Type:Muscle
F15Treatment:SW | Tissue Type:Plasma
Data matrix
  logo